Macrophages can undergo polarization from the M2 to M1 phenotype through ACSL4-induced ferroptosis and STING activation, suggesting that ACSL4 activation is a promising strategy for macrophage reprogramming in cancer therapy(Fig. 2)(Cao 2024;, Chen 2023). This evidence concerns the gene ACSL4 and cancer.